|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.550 USD | +0.79% |
|
+4.08% | -98.94% |
| Market Cap | 82.16M 71.86M 66.28M 61.22M 116M 7.84B 118M 792M 311M 3.86B 308M 302M 13.27B | P/E 2025 * |
-
| P/E 2026 | -0.18x |
|---|---|---|---|---|---|
| Enterprise Value | 54.96M 48.07M 44.34M 40.95M 77.7M 5.24B 79.01M 530M 208M 2.58B 206M 202M 8.88B | EV / Sales 2025 |
9.81x | EV / Sales 2026 | -22.6x |
| Free-Float |
99% | Yield 2025 * |
-
| Yield 2026 | - |
| 1 day | +0.79% | ||
| 1 week | +4.08% | ||
| Current month | +20.85% | ||
| 1 month | -0.78% | ||
| 3 months | +9.91% | ||
| 6 months | -88.05% | ||
| Current year | -98.94% |
| 1 week | 2.31 | 2.82 | |
| 1 month | 1.89 | 2.93 | |
| Current year | 1.25 | 1,046.98 | |
| 1 year | 1.25 | 1,046.98 | |
| 3 years | 1.25 | 11,249.94 | |
| 5 years | 1.25 | 1,000,000 | |
| 10 years | 1.25 | 1,000,000 |
| Manager | Title | Age | Since |
|---|---|---|---|
Sze Beng Lim
CEO | Chief Executive Officer | - | 2025-01-19 |
Feng Zhou
CEO | Chief Executive Officer | 34 | 2017-07-03 |
Xiaodong Pan
DFI | Director of Finance/CFO | 49 | 2022-01-30 |
| Director | Title | Age | Since |
|---|---|---|---|
Feng Zhou
CHM | Chairman | 34 | 2017-07-03 |
Jun Zheng
BRD | Director/Board Member | 49 | 2018-12-30 |
Xiaodong Ji
BRD | Director/Board Member | 57 | 2021-05-21 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +0.79% | +4.08% | -99.03% | -99.96% | 82.16M | ||
| -0.86% | -2.09% | +49.88% | +169.76% | 1,060B | ||
| +0.26% | -2.30% | +63.79% | +62.56% | 619B | ||
| -0.44% | -4.98% | +28.91% | +83.79% | 438B | ||
| -0.80% | +0.54% | +29.45% | +24.66% | 333B | ||
| -0.05% | -1.17% | +28.22% | +46.15% | 282B | ||
| -1.31% | -10.75% | +18.03% | +21.82% | 267B | ||
| -0.05% | +0.09% | -27.49% | -38.54% | 218B | ||
| -0.72% | -2.88% | +23.07% | +61.02% | 196B | ||
| -0.47% | -1.10% | +18.41% | +69.98% | 161B | ||
| Average | -0.31% | -2.59% | +13.32% | +40.13% | 357.4B | |
| Weighted average by Cap. | -0.46% | -3.10% | +36.11% | +83.17% |
| 2025 | 2026 | |
|---|---|---|
| Net sales | 1.74M 1.52M 1.4M 1.3M 2.46M 166M 2.5M 16.78M 6.59M 81.8M 6.54M 6.39M 281M | 1.14M 995K 918K 848K 1.61M 109M 1.64M 10.97M 4.31M 53.47M 4.27M 4.18M 184M |
| Net income | -3.3M -2.89M -2.67M -2.46M -4.67M -315M -4.75M -31.85M -12.51M -155M -12.4M -12.13M -534M | -6.21M -5.43M -5.01M -4.62M -8.77M -592M -8.92M -59.82M -23.49M -292M -23.3M -22.79M -1B |
| Net Debt | -17.25M -15.09M -13.92M -12.86M -24.39M -1.65B -24.8M -166M -65.31M -811M -64.78M -63.37M -2.79B | -27.2M -23.79M -21.94M -20.27M -38.46M -2.59B -39.11M -262M -103M -1.28B -102M -99.91M -4.39B |
Employees
56
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-10 | US$2.550 | +0.79% | 22,134 |
| 26-07-09 | US$2.530 | -0.78% | 11,819 |
| 26-07-08 | US$2.550 | +3.66% | 87,992 |
| 26-07-07 | US$2.460 | +2.93% | 36,539 |
- Stock Market
- Stocks
- SXTC Stock
Select your edition
All financial news and data tailored to specific country editions
















